This protocol is judged by an institutional evaluation board, an independent team that reviews any scientific trials involving people. If a examine will involve a Schedule I drug, as soon as the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) variety within the FDA.Consumers described lit